Revenue
2017
2018
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $4.8M | $4.3M |
| Gross profit | — | — | — | — | — | — | — | −$2.0M | −$1.8M |
| Research & development | — | — | — | — | — | — | — | $578,000 | $423,000 |
| Operating expenses | $77.5M | $60.4M | $36.3M | $105.3M | $46.1M | $30.6M | $15.7M | $23.7M | — |
| Net income | −$75.4M | −$15.2M | $1.29B | −$93.6M | −$38.5M | −$36.2M | $51.7M | −$28.3M | −$33.3M |
| Basic EPSper diluted share | -$0.47 | -$0.09 | $8.29 | -$0.70 | -$0.32 | -$0.38 | $0.58 | -$0.32 | -$0.44 |
| Diluted EPSper diluted share | -$0.47 | -$0.09 | $8.02 | -$0.70 | -$0.32 | -$0.39 | $0.56 | -$0.32 | -$0.44 |